🧬mRNA Therapeutics
Messenger RNA technology for vaccines and therapeutics — the platform behind COVID vaccines, now expanding to cancer and rare diseases.
Market Cap$300.4B
1D-1.31%
Companies33
Public Cos6
SECTOR MARKET CAP
$300.4B+2739.0%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $153.4B | PFE |
| 2 |  | United Kingdom | $103.7B | GSK |
| 3 |  | Germany | $22.4B | BNTX |
| 4 |  | United States | $20.4B | MRNA |
| 5 |  | United States | $436.2M | MRVI |
| 6 |  | United States | $7.2M | ERNA |